Givaudan | GIVN - Cash And Equivalent



Givaudan reported CHF603M in Cash and Equivalent for its fiscal semester ending in June of 2024.


Cash And Equivalent Change Date
Air Liquide EUR 1.92B 0 Jun/2025
Akzo Nobel EUR 1.55B 47M Jun/2025
Anheuser-Busch USD 7.06B 4.11B Jun/2025
Arkema EUR 1.12B 895M Mar/2025
Associated British Foods GBP 758M 565M Mar/2025
BASF EUR 2.52B 203M Jun/2025
Bayer EUR 4.56B 542M Jun/2025
Beiersdorf EUR 1.17B 40M Jun/2025
British American Tobacco GBP 5.93B 1.28B Jun/2024
Covestro EUR 489M 253M Jun/2025
Croda International GBP 166.8M 42.5M Dec/2024
Danone EUR 1.62B 144M Jun/2025
Diageo GBP 2.2B 544M Jun/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.72B 644.08M Jun/2025
Givaudan CHF 603M 3M Jun/2024
Glanbia USD 417M 116.1M Jan/2025
Heineken EUR 2.07B 284M Jun/2025
Henkel EUR 2.87B 18M Jun/2025
International Flavors Fragrances USD 816M 203M Jun/2025
Johnson Matthey GBP 898M 277M Mar/2025
Lonza CHF 1.11B 286M Dec/2024
L'Oréal EUR 4.82B 769.6M Jun/2025
Merck EUR 1.17B 161M Jun/2025
Nestle CHF 4.65B 904M Jun/2025
Pernod Ricard EUR 1.94B 748M Dec/2024
Reckitt Benckiser GBP 880M 106M Dec/2024
SGS CHF 1.21B 78M Dec/2024
Sika AG CHF 707.5M 59.3M Dec/2024
Solvay EUR 333M 118M Jun/2025
Tate & Lyle GBP 334M 260M Mar/2025
Umicore EUR 2.01B 712.6M Dec/2024
Victrex 25.4M 3.9M Mar/2025